DSIP vs Thymosin Alpha-1

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

DSIP

Delta Sleep-Inducing Peptide is a neuropeptide that promotes delta wave sleep, the deepest and most restorative phase of the sleep cycle.

Full details →

Thymosin Alpha-1

Thymosin Alpha-1 is a peptide naturally produced by the thymus gland that plays a crucial role in immune system modulation. It is approved in over 35 countries for various conditions including hepatitis B and C.

Full details →

Side-by-Side Comparison

Aspect	DSIP	Thymosin Alpha-1
Dose Range	100 mcg–300 mcg	1.6 mg–3.2 mg
Frequency	1x daily	Less than daily
Cycle Length	1–6 weeks	4–12 weeks
Route	subcutaneous	subcutaneous
Mechanism	Modulates sleep-wake cycles by affecting sleep spindles and delta rhythms. May also influence stress hormones and have analgesic properties.	Enhances T-cell function and maturation, stimulates dendritic cell activity, and modulates cytokine production. Promotes the differentiation of stem cells into mature T lymphocytes.
Typical Dosage	Typical dosing: 100-300mcg administered 30 minutes before sleep. Some protocols use it cyclically.	Clinical dosing typically ranges from 1.6mg to 6.4mg administered subcutaneously 2-3 times weekly. Research protocols may vary.
Administration	Subcutaneous or intramuscular injection before bedtime. Some users report better results with cyclical use.	Subcutaneous injection. Often used in cycles or as part of comprehensive immune support protocols.
Side Effects	May cause grogginess upon waking, vivid dreams, or temporary headaches.	Generally well-tolerated. Rare side effects include injection site reactions, mild flu-like symptoms, and temporary fatigue.
Best For	Recovery & Healing Sleep Quality	Recovery & Healing